We are live on ! Find out more
ALT icon

Altimmune
ALT

172 hedge funds and large institutions have $453M invested in Altimmune in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 29

77% more call options, than puts

Call options by funds: $20.6M | Put options by funds: $11.6M

37% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 38

20% more funds holding

Funds holding: 143 → 172 (+29)

18.46% more ownership

Funds ownership: 64.32% → 82.78% (+18%)

16% more capital invested

Capital invested by funds: $389M → $453M (+$63.9M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
172
Holders Change
+29
Holders Change %
+20.28%
% of All Funds
2.48%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
59
Increased
52
Reduced
38
Closed
29
Calls
$20.6M
Puts
$11.6M
Net Calls
+$8.98M
Net Calls Change
-$3.81M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$77.7M
2
Millennium Management
Millennium Management
New York
+$14.4M
3
PCM
Portolan Capital Management
Massachusetts
+$9.02M
4
Rafferty Asset Management
Rafferty Asset Management
New York
+$8.98M
5
RAM
Readystate Asset Management
Illinois
+$8.4M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$25.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.6M
3
N
Nuveen
North Carolina
-$8.28M
4
Invesco
Invesco
Georgia
-$7.31M
5
TIM
Timelo Investment Management
Ontario, Canada
-$5.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
Aviva
101
Aviva
United Kingdom
$234K – – –
CSS
102
Cubist Systematic Strategies
Connecticut
$232K -$1.24M -122,155 -84%
IAA
103
Independent Advisor Alliance
North Carolina
$224K +$122K +12,000 +120%
New York State Common Retirement Fund
104
New York State Common Retirement Fund
New York
$217K -$539 -53 -0.2%
Manulife (Manufacturers Life Insurance)
105
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$210K +$661 +65 +0.3%
IWC
106
Integrated Wealth Concepts
Massachusetts
$204K – – –
US Bancorp
107
US Bancorp
Minnesota
$202K +$202K +19,817 New
Bank of Montreal
108
Bank of Montreal
Ontario, Canada
$187K +$213K +20,965 New
UBS AM
109
UBS AM
Illinois
$185K +$185K +18,200 New
MMA
110
Miracle Mile Advisors
California
$173K – – –
DFCM
111
Dark Forest Capital Management
Puerto Rico
$164K +$164K +16,105 New
Walleye Trading
112
Walleye Trading
New York
$159K -$468K -46,021 -75%
T. Rowe Price Associates
113
T. Rowe Price Associates
Maryland
$156K +$18.5K +1,821 +14%
BCI
114
Brinker Capital Investments
Pennsylvania
$152K +$488 +48 +0.3%
OPS
115
Orion Portfolio Solutions
Nebraska
$152K +$488 +48 +0.3%
ASRS
116
Arizona State Retirement System
Arizona
$150K +$150K +14,766 New
WE
117
Wealth Effects
Massachusetts
$150K +$150K +14,700 New
TI
118
Tidal Investments
Wisconsin
$141K +$141K +13,827 New
CFM
119
Catalyst Funds Management
Australia
$140K +$140K +13,800 New
Squarepoint
120
Squarepoint
New York
$134K -$1.01M -99,595 -88%
TCM
121
Teza Capital Management
Illinois
$125K +$125K +12,326 New
Teacher Retirement System of Texas
122
Teacher Retirement System of Texas
Texas
$122K +$122K +11,962 New
BWP
123
Bernardo Wealth Planning
Pennsylvania
$121K +$121K +11,913 New
Creative Planning
124
Creative Planning
Kansas
$120K -$3.05K -300 -2%
Fidelity Investments
125
Fidelity Investments
Massachusetts
$113K -$519K -50,994 -82%
3 4
5
6 7

ALT Hedge Fund Activity: Q1 2024 in Review

172 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2024, worth a combined $453M — up 16% from $389M a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new ALT positions and 29 closed out — a net gain of 30 holders — while 52 added to existing stakes and 38 trimmed.

The largest buyer was State Street, adding an estimated $77.7M. The largest seller was Ameriprise, cutting an estimated $25.2M.

  • 172 institutional investors held Altimmune (ALT) as of Q1 2024, up from 143 in Q4 2023.
  • Funds reported $453M of Altimmune stock for Q1 2024, up 16% quarter-over-quarter.
  • 59 funds opened new Altimmune positions in Q1 2024 and 29 closed out, a net change of +30 holders.
  • The largest Altimmune buyer in Q1 2024 was State Street, an estimated $77.7M added.
  • The largest Altimmune seller in Q1 2024 was Ameriprise, an estimated $25.2M sold.

Based on aggregated 13F filings for Q1 2024.